topotecan and Sensitivity and Specificity

Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Disease Progression; Drug Administration Schedule; Female; Humans; Incidence; Infusions, Intravenous; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Quality of Life; Sensitivity and Specificity; Survival Analysis; Topotecan

Topics: Administration, Oral; Adolescent; Adult; Biological Availability; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Maximum Tolerated Dose; Neoplasms; Salvage Therapy; Sampling Studies; Sensitivity and Specificity; Topotecan; Treatment Outcome

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Survival Rate; Topotecan; Treatment Outcome; Vinblastine; Vinorelbine

Topics: Chromatography, High Pressure Liquid; Drug Stability; Humans; Linear Models; Methanol; Reproducibility of Results; Sensitivity and Specificity; Specimen Handling; Spectrometry, Fluorescence; Topotecan

Topics: Animals; Antiemetics; Antineoplastic Agents; Chromatography, Liquid; Drug Interactions; Duodenum; Hydrogen-Ion Concentration; Least-Squares Analysis; Male; Mass Spectrometry; Models, Biological; Ondansetron; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Topotecan

Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Fluorescence; Irinotecan; Lasers; Pharmaceutical Preparations; Photochemistry; Sensitivity and Specificity; Spectrometry, Fluorescence; Topotecan

Topics: Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carcinoma, Endometrioid; Cystadenocarcinoma, Serous; Deoxycytidine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Luminescent Measurements; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Topotecan

Topics: Antineoplastic Agents; Apoptosis; Biosensing Techniques; Cell Line, Tumor; Cell Separation; Cell Survival; Dielectric Spectroscopy; Drug Evaluation, Preclinical; Equipment Design; Equipment Failure Analysis; Flow Cytometry; Humans; Neoplasms, Experimental; Reproducibility of Results; Sensitivity and Specificity; Topotecan; Transistors, Electronic; Treatment Outcome

Topics: Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Camptothecin; Caspase 3; Caspase 9; Caspases; Cell Adhesion; Enzyme Activation; Enzyme Precursors; Female; Fibronectins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression Regulation, Neoplastic; Humans; Oligonucleotides, Antisense; Poly(ADP-ribose) Polymerases; Protein-Tyrosine Kinases; Sensitivity and Specificity; Topotecan; Tumor Cells, Cultured; Tumor Protein, Translationally-Controlled 1

Topics: Animals; Antibodies; Antineoplastic Agents; Chromatography, High Pressure Liquid; Mice; Mice, Inbred BALB C; Reproducibility of Results; Sensitivity and Specificity; Topotecan

Topics: Carboxylic Acids; Chromatography, High Pressure Liquid; Drug Stability; Humans; Lactones; Reproducibility of Results; Sensitivity and Specificity; Topotecan

Topics: Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Drug Stability; Feasibility Studies; Humans; Hydrophobic and Hydrophilic Interactions; Mice; Molecular Structure; Reproducibility of Results; Sensitivity and Specificity; Specimen Handling; Spectrometry, Fluorescence; Tissue Distribution; Topotecan

Topics: Antipyrine; Atenolol; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Chromatography, High Pressure Liquid; Drug Stability; Furosemide; Humans; Intestinal Absorption; Permeability; Propranolol; Reproducibility of Results; Sensitivity and Specificity; Topotecan

Topics: Algorithms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Data Interpretation, Statistical; Etoposide; Feasibility Studies; Follow-Up Studies; Humans; Linear Models; Lung Neoplasms; Programming Languages; Research Design; Sensitivity and Specificity; Software; Survival Rate; Topotecan

Topics: Camptothecin; Chromatography, High Pressure Liquid; Drug Stability; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Hydrolysis; Hydroxy Acids; Kinetics; Regression Analysis; Sensitivity and Specificity; Topoisomerase I Inhibitors; Topotecan

Topics: Adenocarcinoma; Antineoplastic Agents; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Division; Cell Survival; Cisplatin; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gemcitabine; Humans; Inhibitory Concentration 50; Irinotecan; Lung Neoplasms; Paclitaxel; Sensitivity and Specificity; Taxoids; Topoisomerase I Inhibitors; Topotecan; Tumor Cells, Cultured

Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Disease Models, Animal; Endothelial Growth Factors; In Situ Nick-End Labeling; Injections, Intraperitoneal; Kidney Neoplasms; Lymphokines; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Reference Values; Sensitivity and Specificity; Survival Rate; Topotecan; Treatment Outcome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Wilms Tumor

Topics: Analysis of Variance; Animals; Dose-Response Relationship, Drug; Drug Administration Schedule; Injections, Intravenous; Male; Models, Animal; Otoacoustic Emissions, Spontaneous; Probability; Rabbits; Sensitivity and Specificity; Statistics, Nonparametric; Topotecan

Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Erythrocytes; Humans; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Topotecan